FDA Recall Terminated

IRISpec" CA/CB two-part urine chemistry control twin set, Iris Diagnostics part number 800-0074. Intended Use: IRISpec CA/CB is an assayed QC material for monitoring of the urine chemistry analytes and devices as listed on the package insert. For in vitro diagnostic (IVD) use only.

Recall: Z-2124-2012 · Initiated July 9, 2012

Recall

Recall Number
Z-2124-2012
Event Number
62555
Firm
Iris Diagnostics
FEI Number
2023446
Product Code
JJW
Status
Terminated
Root Cause
Nonconforming Material/Component
Initiated
July 9, 2012
Posted
August 1, 2012
Terminated
January 27, 2014
Address
9172 Eton Ave, Chatsworth, CA, 91311-5805

Description

IRISpec" CA/CB two-part urine chemistry control twin set, Iris Diagnostics part number 800-0074. Intended Use: IRISpec CA/CB is an assayed QC material for monitoring of the urine chemistry analytes and devices as listed on the package insert. For in vitro diagnostic (IVD) use only.

Reason

The firm recalled after it received complaints of IRISpec CA/CB two part Urine Chemistry Control, 101131-12, where the nitrite results read negative for the part B control, which should be positive.

Action

The firm initiated the recall on 07/09/12 by sending out a Medical Device Recall notification to customers via e-mail. The recall notification identified the affected product, reason for recall, and instructions on the recall. Customers were to confirm how many sets of unopened or partially opened IRISpec CA/CB that was in their inventory, dispose of the affected product, and provide written confirmation of the product's disposition. The letter also stated that Iris Diagnostics would replace any unused inventory that was returned at no charge to the customer. Contact information for the recall was also provided. The communications also included a fax response sheet for return/replacement.

Distribution

Nationwide Distribution

Quantity

862